Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (31-40 of 213) with videos related to

Pageof 22
Sort By:
Australian Journal of Primary Health|September 7, 2012
Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapyChristine Longman, Meredith Temple-Smith, Gail Gilchrist, et al.
Drug and Alcohol Review|March 2, 2011
Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisationChristine Longman, Nicholas Lintzeris, Meredith Temple-Smith, et al.
Australian and New Zealand Journal of Public Health|February 25, 2009
Fast-tracking implementation through trial design: the case of buprenorphine treatment in VictoriaGabriele Bammer, Alison Ritter, Jozica J Kutin, et al.
European Addiction Research|March 18, 2006
Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatmentTimothy B Mitchell, Nicholas Lintzeris, Alyson Bond, et al.
Drug and Alcohol Review|March 2, 2011
Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?Soraya Mayet, Michael Gossop, Nicholas Lintzeris, et al.
Journal of Cannabis Research|October 28, 2025
Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in AustraliaNicholas Lintzeris, Jonathon C Arnold, Iain S McGregor, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 10, 2018
Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoidsNathan I Jacobs, Mark Montebello, Lauren A Monds, et al.
Journal of Substance Abuse Treatment|November 14, 2008
Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependenceGayle Ridge, Michael Gossop, Nicholas Lintzeris, et al.
CNS Drugs|March 19, 2020
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic ReviewKrista J Siefried, Liam S Acheson, Nicholas Lintzeris, et al.
Drug and Alcohol Dependence Reports|September 15, 2025
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabisLlewellyn Mills, Jonathon C Arnold, Iain S Mcgregor, et al.
Pageof 22

Showing results (31-40 of 213) with videos related to

Sort By:
Pageof 22
Australian Journal of Primary Health|September 7, 2012
Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapyChristine Longman, Meredith Temple-Smith, Gail Gilchrist, et al.
Drug and Alcohol Review|March 2, 2011
Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisationChristine Longman, Nicholas Lintzeris, Meredith Temple-Smith, et al.
Australian and New Zealand Journal of Public Health|February 25, 2009
Fast-tracking implementation through trial design: the case of buprenorphine treatment in VictoriaGabriele Bammer, Alison Ritter, Jozica J Kutin, et al.
European Addiction Research|March 18, 2006
Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatmentTimothy B Mitchell, Nicholas Lintzeris, Alyson Bond, et al.
Drug and Alcohol Review|March 2, 2011
Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?Soraya Mayet, Michael Gossop, Nicholas Lintzeris, et al.
Journal of Cannabis Research|October 28, 2025
Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in AustraliaNicholas Lintzeris, Jonathon C Arnold, Iain S McGregor, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 10, 2018
Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoidsNathan I Jacobs, Mark Montebello, Lauren A Monds, et al.
Journal of Substance Abuse Treatment|November 14, 2008
Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependenceGayle Ridge, Michael Gossop, Nicholas Lintzeris, et al.
CNS Drugs|March 19, 2020
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic ReviewKrista J Siefried, Liam S Acheson, Nicholas Lintzeris, et al.
Drug and Alcohol Dependence Reports|September 15, 2025
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabisLlewellyn Mills, Jonathon C Arnold, Iain S Mcgregor, et al.
Pageof 22